Main Article Content
Use of a simple pain model to evaluate analgesic activity of ibuprofen versus paracetamol
Abstract
Objective: To evaluate the analgesic activity of ibuprofen against paracetamol using a simple pain model.
Design: A double-blind study.
Setting: Twenty general practitioners in Harare, Zimbabwe.
Patients: Adults with acute sore throat of a maximum of two days’ duration.
Interventions: One hundred and thirteen patients with acute pain associated with tonsillopharyngitis randomly received either 400mg ibuprofen or 1000mg paracetamol. The study design included repeated administration up to 48 hours to assess tolerability.
Main outcome measures: At hourly intervals for six hours after the first dose of treatment, the patients evaluated pain intensity on swallowing, difficulty in swallowing and global pain relief according to visual analogue scales.
Results: Ibuprofen 400mg was significantly more effective than paracetamol 1000mg in all three ratings, at all time-points for pain intensity and difficulty in swallowing, and from two hours onwards for pain relief. There were no serious adverse effects and no statistically
significant difference in the incidence of adverse effects in the two treatment groups.
Conclusions: Sore throat pain provided a sensitive model to assess the analgesic efficacy of class I analgesics and discriminated between the analgesic efficacy of ibuprofen and paracetamol.
Design: A double-blind study.
Setting: Twenty general practitioners in Harare, Zimbabwe.
Patients: Adults with acute sore throat of a maximum of two days’ duration.
Interventions: One hundred and thirteen patients with acute pain associated with tonsillopharyngitis randomly received either 400mg ibuprofen or 1000mg paracetamol. The study design included repeated administration up to 48 hours to assess tolerability.
Main outcome measures: At hourly intervals for six hours after the first dose of treatment, the patients evaluated pain intensity on swallowing, difficulty in swallowing and global pain relief according to visual analogue scales.
Results: Ibuprofen 400mg was significantly more effective than paracetamol 1000mg in all three ratings, at all time-points for pain intensity and difficulty in swallowing, and from two hours onwards for pain relief. There were no serious adverse effects and no statistically
significant difference in the incidence of adverse effects in the two treatment groups.
Conclusions: Sore throat pain provided a sensitive model to assess the analgesic efficacy of class I analgesics and discriminated between the analgesic efficacy of ibuprofen and paracetamol.
